Ro-281675

SynDRA canonical compound SYN0021934 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	GCK
Mechanism of action	Glucokinase activator

All known targets

GCK

Mechanisms of action (all sources)

Glucokinase activator

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

GCKR
HDAC6

Cross-references

PubChem CID: 9886086
ChEMBL: CHEMBL1096435
ChEBI: 95004
PDB: 4DC
LINCS BRD: BRD-K21672174

Synonyms

Ro-28-1675
RO-28-1675
C18H22N2O3S2
RO-0281675
NEQSWPCDHDQINX-MRXNPFEDSA-N
orb1706690
SCHEMBL2645615
CHEBI:95004
GLXC-04289
BDBM50346020
MFCD12546328
AKOS030526774
DA-67253
HY-10595
MS-26184
Ro 28-1675?
(R)-RO 28-0450
RO-181675
E98859
T16793
RO-181675-000
BRD-K21672174-001-01-4
BRD-K21672174-001-03-0
4DC
(2R)-3-cyclopentyl-2-(4-methylsulfonylphenyl)-N-(2-thiazolyl)propanamide
Ro 0281675
(2R)-3-Cyclopentyl-2-[4-(methanesulfonyl)phenyl]-N-(thiazol-2-yl)propionamide

Look up Ro-281675 in the interactive SynDRA portal →